 |
Vemurafenib |
|---|---|
| Trade Name | |
| Orphan Indication | Erdheim-Chester syndrome |
| EU Market Approval | EU |
| EU Designation Date | 2017-02-27 00:00:00 |
| Sponsor | Groupe d'étude des histiocytoses |
| |
Vemurafenib |
|---|---|
| Trade Name | |
| Orphan Indication | Erdheim-Chester syndrome |
| EU Market Approval | EU |
| EU Designation Date | 2017-02-27 00:00:00 |
| Sponsor | Groupe d'étude des histiocytoses |